We collected information about Axsome Therapeutics Hours for you. Follow the liks to find out everything about Axsome Therapeutics Hours.
https://www.nasdaq.com/market-activity/stocks/axsm/after-hours
Axsome Therapeutics, Inc. Common Stock (AXSM) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
Axsome is developing innovative treatments including AXS-05, AXS-07, AXS-12, and AXS-14. Learn about our pipeline Axsome focuses on CNS conditions including depression, Alzheimer's disease agitation, migraine, narcolepsy and fibromyalgia.
https://www.axsome.com/contact-us
AXSOME THERAPEUTICS, INC. 22 Cortlandt St., 16th floor New York, NY 10007 Phone: +1(212)332-3241 +1(212)332-3241 Fax: +1(212)320-0245 Email: [email protected]. If you are a U.S. Healthcare Professional and would like to receive more information please click here. First Name.
https://www.barrons.com/market-data/stocks/axsm
Sep 10, 2021 · Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 ...Price: $21.62
https://www.marketwatch.com/investing/Stock/AXSM
Sep 15, 2021 · Axsome Therapeutics price target cut to $55 from $118 at Mizuho, stock rated buy. Aug. 11, 2021 at 8:54 a.m. ET by Tonya Garcia.1 Month: 19.50%
https://finance.yahoo.com/quote/AXSM/profile
Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New ...
https://www.msn.com/en-us/health/medical/axsome-axsm-begins-late-stage-sleep-disorder-study-on-axs-12/ar-AAOym1s
Axsome Therapeutics, Inc. AXSM announced that it has initiated enrollment in the phase III study — SYMPHONY — which will evaluate its pipeline candidate, AXS-12, in patients with narcolepsy, a ...
https://www.nasdaq.com/articles/why-axsome-therapeutics-stock-cratered-in-august-2021-09-08
Sep 08, 2021 · Axsome Therapeutics (NASDAQ: AXSM), a clinical-stage biotech focused on the development of drugs for central nervous system disorders, had a seriously rough August. The biotech's shares slipped by ...
Searching for Axsome Therapeutics Hours?
You can just click the links above. The info is collected for you.
